InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-33.5%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by STOKELY DAN, Chief Financial Officer. Officer active across 1 company, notably Ampio Pharmaceuticals, Inc.. Cumulatively, 10 reports have been logged. Activity tracked since 17 May 2021. The latest transaction was disclosed on 1 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
22,914 shares@ US$0.575.55% mcap8.0% of flowCommon StockSEC:0001415889-22-000260:0
22,914 shares@ US$0.575.55% mcap16.1% of flowCommon StockSEC:0001415889-22-000260
28,127 shares@ US$1.6419.13% mcap27.7% of flowCommon StockSEC:0001415889-21-005020:0
28,127 shares@ US$1.6427.7% of flowCommon StockSEC:0001415889-21-005020
335,000 shares0Common StockSEC:0001415889-21-004869:0
335,000 shares0Common StockSEC:0001415889-21-004869
22,500 shares@ US$0.435.6% of flowCommon StockSEC:0001415889-21-003253
22,500 shares@ US$0.433.90% mcap5.6% of flowCommon StockSEC:0001415889-21-003253:0
35,000 shares@ US$0.435.96% mcap8.6% of flowCommon StockSEC:0001415889-21-002569:0
35,000 shares@ US$0.438.6% of flowCommon StockSEC:0001415889-21-002569
10 of 10 declarations
About STOKELY DAN
Dan Stokely is the CFO of Ampio Pharmaceuticals, Inc. He oversees all financial operations of the company, including financial planning, reporting, and compliance. In his role, Dan ensures that Ampio maintains high standards of financial integrity and transparency. His experience in finance is crucial to support Ampio's growth strategy.
